on Piramal Pharma Solutions
Piramal Pharma Solutions Achieves High Net Promoter Score
Piramal Pharma Solutions, a key player in the Contract Development and Manufacturing Organization sector, has recently attained a remarkable Net Promoter Score (NPS) of 55. This score is significantly higher than the industry norm, highlighting the company’s commitment to stakeholder focus and operational excellence. The survey and score were validated by DNV, an independent assurance expert, ensuring credibility.
NPS is an essential metric for assessing customer loyalty, indicating how likely customers are to recommend the company’s services. Piramal Pharma's high score reflects their dedication to going beyond mere customer satisfaction, aiming for customer delight through strategic engagements guided by customer insights.
This achievement reinforces Piramal Pharma Solutions’ leadership role among competitor CDMOs, emphasizing their continuous improvement in service offerings and process optimization to deliver high value to stakeholders globally.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Piramal Pharma Solutions news